Project Grant R56NS134632
Award Date
9/21/23
Completion Date
8/31/24
Dollars Obligated
$646K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $2,208,982 to the San Diego Biomedical Research Institute to conduct research on the role of interleukin-13 (IL-13) and its receptor IL-13RA1 in the pathogenesis of Parkinson's disease. The research aims to elucidate the molecular and cellular mechanisms by which...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $655,329 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Albert Einstein College of Medicine in Bronx, NY. The grant will fund research to determine the role of the GPNMB gene in the pathogenesis of Parkinson's disease, Lewy body dementia, and related synucleinopathies. The research will integrate genome-wide association study data with epigenetic...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program provides $670,600 to The Johns Hopkins University to support research on the role of microglia in Parkinson's disease progression. The key objectives are to determine whether microglia activation, as measured by CSF1R density using a novel PET radioligand, correlates with...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to investigate the role of T-lymphocytes in the pathogenesis of Parkinson's disease (PD). The $142,686 award will support a comprehensive study to characterize the immune cell expression and T-cell receptor repertoire in PD patients, prodromal patients at...
This $227,205 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate the effects of the Parkinson's disease-associated protein LRRK2 on lysosomal function and inflammatory activity in microglia. The primary objectives are to: 1) examine how LRRK2 and the Parkinson's disease risk gene GBA1 interact to regulate lysosomal...
This $173,140 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of California, San Francisco (UCSF) to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons associated with Parkinson's disease. The project aims to utilize novel mouse models to chronically manipulate the...
This $475,475 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The goal of the award is to evaluate a small molecule inhibitor of the USP30 enzyme as a potential neuroprotective therapy for Parkinson's disease. The research will assess...
This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on exploring the role of neuromelanin accumulation in dopamine neurons and its impact on Parkinson's disease. The $616,200 award to the Oklahoma Medical Research Foundation (OMRF) will support experiments to investigate how progressive neuromelanin buildup in mouse...
This National Institute on Aging (NIA) Project Grant award (CFDA 93.866 - Aging Research) provides $237,160 to Northwestern University to investigate the role of striatal astrocytic dopamine D2 receptor signaling in the pathogenesis of LRRK2-mediated Parkinson's disease. The project aims to mechanistically link impaired D2 receptor signaling and inflammation in striatal astrocytes expressing the LRRK2G2019S mutation, a common genetic cause of familial Parkinson's disease. The research will...
This federal Project Grant award of $499,286.59, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to elucidate the relationship between oxidative stress and the LRRK2 protein in the pathogenesis of Parkinson's disease. The 4-year project, with an award period of August 23, 2024 to July 31, 2028, focuses on three broad aims: 1) examining...